Huntingdon Life Sciences (HLS) is in eleventh-hour talks with an unidentified US financial group to avert closure in the next 36 hours.
The American company is weighing up a cash infusion of £20m to secure the future of HLS.
HLS
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
